Table 3 Crude and adjusted Cox regressions of the association between the individual biomarkers and ischemic stroke recurrence, death and the composite endpoint (ischemic stroke recurrence and death)

CRP¹⁾

0.90

(0.44, 1.83)

0.772

0.86

(0.41, 1.77)

0.674

0.92

(0.44, 1.90)

0.816

IL-6

1.11

(0.67, 1.86)

0.686

1.19

(0.52, 1.97)

0.578

1.10

(0.30, 2.02)

0.754

Neopterin

1.34

(0.85, 2.11)

0.209

1.45

(0.82, 2.57)

0.201

1.39

(0.80, 2.41)

0.244

PAr

1.16

(0.71, 1.90)

0.553

1.13

(0.61, 2.10)

0.692

1.24

(0.67, 2.31)

0.494

KA

0.91

(0.55, 1.50)

0.710

0.82

(0.41, 1.61)

0.563

0.89

(0.43, 1.86)

0.761

CRP¹⁾

1.81

(1.29, 2.53)

0.001

1.40

(1.01, 1.96)

0.046

1.41

(1.00, 1.99)

0.053

IL-6

1.74

(1.20, 2.51)

0.003

1.34

(0.87, 2.07)

0.181

1.36

(0.87, 2.12)

0.173

Neopterin

1.93

(1.43, 2.61)

< 0.001

1.44

(0.89, 2.33)

0.136

1.55

(0.91, 2.64)

0.104

PAr

1.69

(1.15, 2.49)

0.008

1.11

(0.68, 1.82)

0.666

1.13

(0.67, 1.90)

0.641

KA

1.12

(0.75, 1.66)

0.577

0.64

(0.38, 1.07)

0.088

0.69

(0.41, 1.14)

0.145

CRP¹⁾

1.59

(1.16, 2.18)

0.004

1.27

(0.92, 1.74)

0.140

1.27

(0.93, 1.74)

0.135

IL-6

1.47

(1.08, 2.02)

0.016

1.23

(0.85, 1.77)

0.274

1.23

(0.85, 1.77)

0.275

Neopterin

1.79

(1.39, 2.31)

< 0.001

1.52

(1.06, 2.20)

0.023

1.55

(1.06, 2.27)

0.025

PAr

1.62

(1.19, 2.22)

0.002

1.28

(0.86, 1.90)

0.224

1.34

(0.89, 2.01)

0.162

KA

1.27

(0.58, 2.79)

0.555

0.55

(0.19, 1.54)

0.252

0.60

(0.21, 1.71)

0.339